Search research articles
Contact Us
Filters
Showing results (141-150 of 178) with videos related to
Page
of 18
Sort By:
JCO Precision Oncology
|
May 26, 2021
Impact of Conditioning Intensity and Genomics on Relapse After Allogeneic Transplantation for Patients With Myelodysplastic Syndrome
Laura W Dillon, Gege Gui, Brent R Logan, et al.
Blood Advances
|
May 26, 2018
Related donor transplants: has posttransplantation cyclophosphamide nullified the detrimental effect of HLA mismatch?
Tara M Robinson, Ephraim J Fuchs, Mei-Jie Zhang, et al.
Blood
|
May 5, 2017
PD-1 blockade for relapsed lymphoma post-allogeneic hematopoietic cell transplant: high response rate but frequent GVHD
Bradley M Haverkos, Diana Abbott, Mehdi Hamadani, et al.
Transplantation and Cellular Therapy
|
July 6, 2025
Allogeneic Hematopoietic Cell Donor Selection: Contemporary Guidelines from the NMDP/CIBMTR
Antonio M Jimenez Jimenez, Stephen R Spellman, Ioannis Politikos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 2, 2021
Randomized Phase III BMT CTN Trial of Calcineurin Inhibitor-Free Chronic Graft-Versus-Host Disease Interventions in Myeloablative Hematopoietic Cell Transplantation for Hematologic Malignancies
Leo Luznik, Marcelo C Pasquini, Brent Logan, et al.
Blood Advances
|
March 21, 2019
Plerixafor alone for the mobilization and transplantation of HLA-matched sibling donor hematopoietic stem cells
Yi-Bin Chen, Jennifer Le-Rademacher, Ruta Brazauskas, et al.
Blood
|
March 13, 2012
Regulation of acute graft-versus-host disease by microRNA-155
Parvathi Ranganathan, Catherine E A Heaphy, Stefan Costinean, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 11, 2015
Atorvastatin for the Prophylaxis of Acute Graft-versus-Host Disease in Patients Undergoing HLA-Matched Related Donor Allogeneic Hematopoietic Stem Cell Transplantation (allo-HCT)
Yvonne A Efebera, Susan Geyer, Leslie Andritsos, et al.
Blood Advances
|
February 25, 2020
KIR B donors improve the outcome for AML patients given reduced intensity conditioning and unrelated donor transplantation
Daniel Weisdorf, Sarah Cooley, Tao Wang, et al.
JAMA Oncology
|
May 2, 2024
Measurable Residual FLT3 Internal Tandem Duplication Before Allogeneic Transplant for Acute Myeloid Leukemia
Laura W Dillon, Gege Gui, Niveditha Ravindra, et al.
Page
of 18
Search research articles
Search
Showing results (141-150 of 178) with videos related to
Sort By:
Page
of 18
JCO Precision Oncology
|
May 26, 2021
Impact of Conditioning Intensity and Genomics on Relapse After Allogeneic Transplantation for Patients With Myelodysplastic Syndrome
Laura W Dillon, Gege Gui, Brent R Logan, et al.
Blood Advances
|
May 26, 2018
Related donor transplants: has posttransplantation cyclophosphamide nullified the detrimental effect of HLA mismatch?
Tara M Robinson, Ephraim J Fuchs, Mei-Jie Zhang, et al.
Blood
|
May 5, 2017
PD-1 blockade for relapsed lymphoma post-allogeneic hematopoietic cell transplant: high response rate but frequent GVHD
Bradley M Haverkos, Diana Abbott, Mehdi Hamadani, et al.
Transplantation and Cellular Therapy
|
July 6, 2025
Allogeneic Hematopoietic Cell Donor Selection: Contemporary Guidelines from the NMDP/CIBMTR
Antonio M Jimenez Jimenez, Stephen R Spellman, Ioannis Politikos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 2, 2021
Randomized Phase III BMT CTN Trial of Calcineurin Inhibitor-Free Chronic Graft-Versus-Host Disease Interventions in Myeloablative Hematopoietic Cell Transplantation for Hematologic Malignancies
Leo Luznik, Marcelo C Pasquini, Brent Logan, et al.
Blood Advances
|
March 21, 2019
Plerixafor alone for the mobilization and transplantation of HLA-matched sibling donor hematopoietic stem cells
Yi-Bin Chen, Jennifer Le-Rademacher, Ruta Brazauskas, et al.
Blood
|
March 13, 2012
Regulation of acute graft-versus-host disease by microRNA-155
Parvathi Ranganathan, Catherine E A Heaphy, Stefan Costinean, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 11, 2015
Atorvastatin for the Prophylaxis of Acute Graft-versus-Host Disease in Patients Undergoing HLA-Matched Related Donor Allogeneic Hematopoietic Stem Cell Transplantation (allo-HCT)
Yvonne A Efebera, Susan Geyer, Leslie Andritsos, et al.
Blood Advances
|
February 25, 2020
KIR B donors improve the outcome for AML patients given reduced intensity conditioning and unrelated donor transplantation
Daniel Weisdorf, Sarah Cooley, Tao Wang, et al.
JAMA Oncology
|
May 2, 2024
Measurable Residual FLT3 Internal Tandem Duplication Before Allogeneic Transplant for Acute Myeloid Leukemia
Laura W Dillon, Gege Gui, Niveditha Ravindra, et al.
Page
of 18